Covariates | Subgroup | DFS | OS | DMFS | LRFS | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HR | 95%CI | P | HR | 95%CI | P | HR | 95%CI | P | HR | 95%CI | P | ||
Post-NAC cfEBV DNAa | cBR vs. Non-cBR | 2.81 | 2.16–3.66 | <0.01 | 2.34 | 1.68–3.26 | <0.01 | 3.45 | 2.43–4.91 | <0.01 | 1.89 | 1.27–2.82 | <0.01 |
Post-NAC MRIa | CR vs. PR | 2.34 | 1.05–5.25 | 0.04 | 2.21 | 0.74–6.62 | 0.16 | 1.79 | 0.68–4.70 | 0.24 | 2.70 | 0.86–8.43 | 0.09 |
CR vs. SD/PD | 4.98 | 2.15–11.55 | <0.01 | 5.24 | 1.69–16.31 | <0.01 | 3.30 | 1.20–9.13 | 0.02 | 5.57 | 1.74–17.85 | <0.01 | |
Response Phenotypesa | G1: cBR+CR (References) | 1.00 | – | – | 1.00 | – | – | 1.00 | – | – | 1.00 | – | – |
G3: cBR+PR | 1.52 | 0.69–3.33 | 0.30 | 1.52 | 0.54–4.34 | 0.43 | 1.03 | 0.40–2.63 | 0.95 | 1.93 | 0.61–6.09 | 0.26 | |
G4: non-cBR+PR | 4.44 | 2.01–9.84 | <0.01 | 3.56 | 1.23–10.29 | 0.02 | 3.91 | 1.52–10.02 | <0.01 | 4.02 | 1.25–12.95 | 0.02 | |
G5: cBR+SD/PD | 2.81 | 1.14–6.95 | 0.03 | 2.51 | 0.77–8.24 | 0.13 | 0.80 | 0.21–3.12 | 0.75 | 5.03 | 1.40–18.01 | 0.01 | |
G6: non-cBR+SD/PD | 6.60 | 2.85–15.29 | <0.01 | 7.18 | 2.391.61 | <0.01 | 5.09 | 1.90–13.63 | <0.01 | 5.04 | 1.48–17.11 | 0.01 |